<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248572</url>
  </required_header>
  <id_info>
    <org_study_id>LTHD-10-03</org_study_id>
    <nct_id>NCT01248572</nct_id>
  </id_info>
  <brief_title>Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL</brief_title>
  <official_title>Evaluation of Lens Effective Position, Stability and Prediction With a 12mm Uniplanar, Biaspheric Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lenstec Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lenstec Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary goal of this study is to determine the effective lens position (ELP) - or&#xD;
      location an intraocular lens (IOL) &quot;sits&quot; in the eye - of the Softec HD IOL. A secondary&#xD;
      study goal is to determine if measures of the eye taken prior to surgery can reliably predict&#xD;
      postoperative ELP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to determine the effective lens position (ELP) of the&#xD;
      study lens, and to report the stability of ELP post-operatively. Additionally, correlations&#xD;
      of ELP to predicted postoperative lens position, capsular bag metrics, preoperative biometry&#xD;
      and age will be statistically analyzed for determination of ELP prediction via one, or a&#xD;
      combination of preoperative variables.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective Lens Position</measure>
    <time_frame>6 Months Postoperative</time_frame>
    <description>The position of the intraocular lens - defined by measurement of the aqueous-containing space between the corneal endothelium and the anterior surface of the intraocular lens - once implanted in the capsular bag.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Softec HD IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Softec HD IOL</intervention_name>
    <description>Posterior chamber intraocular lens intended for the replacement of the human crystalline lens following phacoemulsification cataract removal in adults over the age of 21.</description>
    <arm_group_label>Softec HD IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;=40 years of age, of any race and either gender&#xD;
&#xD;
          -  Operable, age related cataract grade 3+ or lower in the study eye&#xD;
&#xD;
          -  Able to achieve best corrected visual acuity (BCVA) 20/30 Snellen or better&#xD;
             postoperatively in the study eye&#xD;
&#xD;
          -  â‰¤1.0 diopter (D) of corneal astigmatism preoperatively in the study eye&#xD;
&#xD;
          -  Able to achieve a dilated pupil &gt;6.0 millimeter (mm) in the study eye&#xD;
&#xD;
          -  Able to adequately visualize the lens equatorial diameter on ultrasound biomicroscopy&#xD;
             (UBM) unit (preoperatively)&#xD;
&#xD;
          -  Desire implantation of a monofocal lenses targeted at emmetropia in the study eye&#xD;
&#xD;
          -  In good general and ocular health&#xD;
&#xD;
          -  Able to competently complete testing&#xD;
&#xD;
          -  Willing and able to attend study visits&#xD;
&#xD;
          -  Willing and able to understand and sign an informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous intraocular surgery or laser treatment&#xD;
&#xD;
          -  Severe dry eye&#xD;
&#xD;
          -  Uncontrolled IOP or glaucoma&#xD;
&#xD;
          -  Retinal or macular pathology (i.e. macular degeneration, proliferative diabetic&#xD;
             retinopathy, etc.)&#xD;
&#xD;
          -  History of retinal detachment&#xD;
&#xD;
          -  Microphthalmia&#xD;
&#xD;
          -  Chronic severe uveitis&#xD;
&#xD;
          -  Corneal decompensation&#xD;
&#xD;
          -  Irregular astigmatism&#xD;
&#xD;
          -  History of corneal disease (e.g., herpes simplex, herpes zoster keratitis, etc.)&#xD;
&#xD;
          -  Clinically significant corneal endothelial dystrophy (e.g., Fuchs' dystrophy)&#xD;
&#xD;
          -  Pseudoexfoliation syndrome&#xD;
&#xD;
          -  Iris atrophy&#xD;
&#xD;
          -  Pupil abnormalities (e.g., corectopia)&#xD;
&#xD;
          -  Aniseikonia&#xD;
&#xD;
          -  Amblyopia&#xD;
&#xD;
          -  An acute or chronic disease or illness that may confound the results of this&#xD;
             investigation (e.g., immunocompromised, connective tissue disease, clinically&#xD;
             significant atopic disease, diabetes, and any other such disease or illness)&#xD;
&#xD;
          -  Pregnant, lactating, or planning to become pregnant during the course of the trial&#xD;
&#xD;
          -  Participation in another clinical trial within 30 days of study start&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Barnet-Dulaney-Perkins Eye Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Centers of Florida</name>
      <address>
        <city>Ft. Myers</city>
        <state>Florida</state>
        <zip>33901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbin Clinic</name>
      <address>
        <city>Rome</city>
        <state>Georgia</state>
        <zip>30165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>March 17, 2014</last_update_submitted>
  <last_update_submitted_qc>March 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>Biaspheric intraocular lens</keyword>
  <keyword>Uniplanar intraocular lens</keyword>
  <keyword>Effective lens position</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

